Bright Minds Biosciences
DRUG74.6305.02% ( +3.570 )
Q2 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Bright Minds Biosciences(DRUG) predict that the EBIT is -9.44 M (-290.6%), Beat estimate;the EPS is -0.782 (-166.7%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B290.62%
-0.01B300.72%
+0.00B10.10%
EPSExceed expectations
-0.7825166.72%
-0.9536225.04%
+0.171158.32%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf